MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.
about
First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response EvaluationMiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathwaysA new mouse avatar model of non-small cell lung cancer.A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression.The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular CorrelationspERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.miR-494-3p is a novel tumor driver of lung carcinogenesis.miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5.Non-Coding RNAs in Primary Liver Cancer.Cost effectiveness of regorafenib as second-line therapy for patients with advanced hepatocellular carcinoma.miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA.PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.Downregulation of miR-329 promotes cell invasion by regulating BRD4 and predicts poor prognosis in hepatocellular carcinoma.MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks.Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
P2860
Q28073654-BE0F623F-2CF3-4397-BBA3-912E3DB75729Q33761894-DF342AE8-2C56-4DDD-BC0C-10561AF79C43Q35141122-00633C60-DDAF-413F-AB45-9BE4B2A0A00EQ35654057-4647765C-BDAA-4F47-A7F1-6DC262950111Q35672901-3B41FCBD-CC16-4269-9F0B-9B7B102A50D0Q35870560-73B1FC1C-8628-4D5E-9523-C09E8620E00FQ36771900-FD33DC09-FF87-4FC7-8DDF-3E5FF4369E59Q36822387-F3FC78FA-1D9D-42CB-98C5-0311CC9237F5Q37702495-0B3F81D5-6673-4571-8BFA-300084B9B434Q38300178-533268E5-E127-4B54-8D93-328A6909CE60Q38541359-0AD7F622-3CE9-4B21-B073-C91A6B706E35Q38702281-9377F45B-E1A7-460F-835C-D8AB42EA874BQ38715236-5B0DE986-3D31-44B0-80B6-8EA72CD3D19EQ38731998-D00C5E0A-6555-4AB4-9BC0-0B69654EF23EQ38828743-714D7BE8-374B-45DC-8E34-F7ECB244F7A5Q41126784-3D454FB5-7DFB-4399-8BDD-15123D27BB4DQ42317922-4EB8BE83-7EAB-40B2-87B5-C564BD3A9709Q47096853-1C4C4640-0D49-46C9-ADBA-8A56E7CC0256Q47247562-F6D19AF4-4C20-4C6B-8A10-BBA44C1186DFQ49800025-66160E70-FBDA-479D-831A-590737164FDAQ50063114-C43B02AB-C1EA-4483-99B0-F4644EBE0814Q55618938-BFDF6773-4101-42DF-BA57-AD597E295620Q57067866-2FCA1AD6-0218-4F81-8D50-2F571D453A3D
P2860
MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.
@en
MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.
@nl
type
label
MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.
@en
MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.
@nl
prefLabel
MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.
@en
MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
MicroRNA-425-3p predicts respo ...... with hepatocellular carcinoma.
@en
P2093
Carlo Carnaghi
Claudia Augello
Elena Rota Caremoli
Gaia Spagnuolo
Marco Maggioni
Massimo Barberis
Tiziana Pressiani
P2860
P304
P356
10.1111/LIV.12636
P50
P577
2014-07-21T00:00:00Z